Earnings Fallout: Oracle's recent quarterly results highlighted robust remaining performance obligations surging to $638 billion, driven by accelerated AI infrastructure demand. Social media chatter focused on the company's aggressive capital expenditure plans and $40 billion financing raise, which contributed to an immediate share price decline. Observers noted that while revenue and earnings beat expectations, the scale of spending for data centers has tempered short-term enthusiasm.

Analyst Reassurance: Mizuho reiterated its outperform rating with a $320 price target, pointing to strong IaaS growth and financing clarity that fell short of prior market concerns. Discussions emphasized the potential for cloud expansion to exceed 50 percent as Oracle positions itself in the AI buildout. Participants described the pullback as a possible entry point amid the firm's expanding backlog.

Long-Term Outlook: The conversation underscored Oracle's massive contracted backlog and customer prepayments that could ease future funding pressures. Many viewed the AI opportunity as substantial, though execution on margins and dilution remains a key watchpoint. Overall sentiment reflected cautious optimism toward sustained infrastructure investments.

Note: This discussion summary was generated from an AI condensation of post data.

Oracle Corporation Insider Trading Activity

Oracle Corporation insiders have traded $ORCL stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:

• DOUGLAS A KEHRING (EVP, Principal Financial Offcr) sold 35,000 shares for an estimated $6,821,149
• CLAYTON M. MAGOUYRK (Chief Executive Officer) has made 0 purchases and 2 sales selling 20,000 shares for an estimated $3,477,470.
• MARK HURA (Pres., Global Field Operations) sold 15,000 shares for an estimated $2,953,314
• STUART LEVEY (EVP, Chief Legal Officer) sold 15,000 shares for an estimated $2,642,850
• NAOMI O SELIGMAN sold 2,223 shares for an estimated $437,064

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Oracle Corporation Revenue

Oracle Corporation had revenues of $19.2B in Q4 2026. This is an increase of 20.63% from the same period in the prior year.

You can track ORCL financials on Quiver Quantitative's ORCL stock page.

You can access data on ORCL stock through the Quiver Quantitative API.

Oracle Corporation Congressional Stock Trading

Members of Congress have traded $ORCL stock 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:

• SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 05/07.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 03/23.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 4 times. They made 1 purchase worth up to $15,000 on 01/30 and 3 sales worth up to $45,000 on 02/24, 12/24, 12/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

Oracle Corporation Hedge Fund Activity

We have seen 1,666 institutional investors add shares of Oracle Corporation stock to their portfolio, and 2,194 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 8,349,915 shares (-16.8%) from their portfolio in Q4 2025, for an estimated $1,627,481,932
• FMR LLC removed 6,391,444 shares (-21.8%) from their portfolio in Q1 2026, for an estimated $913,912,577
• VANGUARD GROUP INC added 5,841,584 shares (+3.5%) to their portfolio in Q4 2025, for an estimated $1,138,583,137
• BNP PARIBAS FINANCIAL MARKETS added 4,942,597 shares (+123.5%) to their portfolio in Q1 2026, for an estimated $706,741,945
• BLACKROCK, INC. removed 4,548,275 shares (-3.1%) from their portfolio in Q1 2026, for an estimated $650,357,842
• CARDANO RISK MANAGEMENT B.V. removed 4,475,051 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $639,887,542
• COATUE MANAGEMENT LLC removed 4,440,008 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $634,876,743

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Oracle Corporation Government Contracts

We have seen $1,505,564,909 of award payments to $ORCL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS: $499,519,521
• EHRM OPERATIONS: $352,649,239
• IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES...: $220,337,868
• EHRM LICENSES AND FEES: $133,449,794
• FORMALLY RECOGNIZE THE CONTRACTORS CORPORATE NAME CHANGE FROM CERNER GOVERNMENT SERVICES INC. TO ORACLE HEA...: $90,849,599

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Oracle Corporation Analyst Ratings

Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Piper Sandler issued a "Overweight" rating on 02/03/2026
• Jefferies issued a "Buy" rating on 01/05/2026

To track analyst ratings and price targets for Oracle Corporation, check out Quiver Quantitative's $ORCL forecast page.

Oracle Corporation Price Targets

Multiple analysts have issued price targets for $ORCL recently. We have seen 28 analysts offer price targets for $ORCL in the last 6 months, with a median target of $247.5.

Here are some recent targets:

• Mark L. Moerdler from Bernstein set a target price of $325.0 on 06/11/2026
• Thomas Blakey from Cantor Fitzgerald set a target price of $284.0 on 06/11/2026
• Raimo Lenschow from Barclays set a target price of $250.0 on 06/11/2026
• Derrick Wood from TD Cowen set a target price of $300.0 on 06/11/2026
• Rishi Jaluria from RBC Capital set a target price of $190.0 on 06/11/2026
• Keith Bachman from BMO Capital set a target price of $220.0 on 06/11/2026
• Patrick Colville from Scotiabank set a target price of $241.0 on 06/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »